Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Mutations in the SARS-CoV-2 spike RBD are responsible for stronger ACE2 binding and poor anti-SARS-CoV mAbs cross-neutralization. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
External reference
Overview of current therapeutics and novel candidates against influenza, respiratory syncytial virus, and middle east respiratory syndrome coronavirus infections
10.3389/fmicb.2019.01327 · 2019 · External reference
The emergence of SARS-CoV-2 in Europe and North America
2020 · External reference
A new coronavirus associated with human respiratory disease in China
2020 · External reference
A pneumonia outbreak associated with a new coronavirus of probable bat origin
2020 · External reference
10.1056/nejmoa2001017
10.1056/nejmoa2001017 · External reference
10.1016/j.meegid.2020.104212
10.1016/j.meegid.2020.104212 · External reference
10.1007/s12035-020-02022-0
10.1007/s12035-020-02022-0 · External reference
10.1006/viro.2000.0757
10.1006/viro.2000.0757 · External reference
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
2020 · External reference
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
2020 · External reference
10.1038/ncomms15092
10.1038/ncomms15092 · External reference
10.1126/science.abb2507
10.1126/science.abb2507 · External reference
The SARS-CoV-2 Spike Variant D614G Favors an Open Conformational State
2020 · External reference
The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity
2020 · External reference
In silico mechanistic analysis of IRF3 inactivation and high-risk HPV E6 species-dependent drug response
10.1038/srep13446 · 2015 · External reference
10.1016/j.biomaterials.2017.02.023
10.1016/j.biomaterials.2017.02.023 · External reference
10.1002/prot.25748
10.1002/prot.25748 · External reference
10.1021/acs.jmedchem.9b00061
10.1021/acs.jmedchem.9b00061 · External reference
Energy-based analysis and prediction of the orientation between light- and heavy-chain antibody variable domains
10.1016/j.jmb.2009.03.043 · 2009 · External reference
10.1016/0022-2836(87)90412-8
10.1016/0022-2836(87)90412-8 · External reference
10.1016/s0022-2836(05)80134-2
10.1016/s0022-2836(05)80134-2 · External reference
10.1074/jbc.m603275200
10.1074/jbc.m603275200 · External reference
10.1016/j.jmb.2009.03.042
10.1016/j.jmb.2009.03.042 · External reference
10.1074/jbc.m600697200
10.1074/jbc.m600697200 · External reference
10.1016/j.cell.2018.12.028
10.1016/j.cell.2018.12.028 · External reference
10.1093/nar/gkw361
10.1093/nar/gkw361 · External reference
Improving B-cell epitope prediction and its application to global antibody-antigen docking
10.1093/bioinformatics/btu190 · 2014 · External reference
10.1038/nmeth.4067
10.1038/nmeth.4067 · External reference
10.1093/bioinformatics/btt055
10.1093/bioinformatics/btt055 · External reference
Optimizing working parameters of the smooth particle mesh Ewald algorithm in terms of accuracy and efficiency
10.1063/1.3446812 · 2010 · External reference
10.1002/(sici)1096-987x(199709)18:12<1463::aid-jcc4>3.0.co;2-h
10.1002/(sici)1096-987x(199709)18:12<1463::aid-jcc4>3.0.co;2-h · External reference
Open Source Drug Discovery C, Lynn A. g_mmpbsa–a GROMACS tool for high-throughput MM-PBSA calculations
10.1021/ci500020m · 2014 · External reference
Insights into the species-specific TLR4 signaling mechanism in response to Rhodobacter sphaeroides lipid A detection
10.1038/srep07657 · 2015 · External reference
10.1016/j.cell.2020.04.004
10.1016/j.cell.2020.04.004 · External reference
10.1101/2020.08.06.238915
10.1101/2020.08.06.238915 · External reference
Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2
2020 · External reference
Structural basis for receptor recognition by the novel coronavirus from Wuhan
2020 · External reference
10.1016/j.cell.2020.03.045
10.1016/j.cell.2020.03.045 · External reference
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein
2020 · External reference
10.1080/22221751.2020.1729069
10.1080/22221751.2020.1729069 · External reference
10.1073/pnas.2008209117
10.1073/pnas.2008209117 · External reference
Molecular Mechanism of Evolution and Human Infection with SARS-CoV-2
2020 · External reference
10.1021/cc0500607
10.1021/cc0500607 · External reference
10.1016/j.virol.2006.01.029
10.1016/j.virol.2006.01.029 · External reference
Investigation of ACE2 N-terminal fragments binding to SARS-CoV-2 Spike RBD
2020 · External reference
De novo design of picomolar SARS-CoV-2 miniprotein inhibitors
2020 · External reference
10.1371/journal.pmed.0030237
10.1371/journal.pmed.0030237 · External reference
Spike protein binding prediction with neutralizing antibodies of SARS-CoV-2
2020 · External reference
10.1128/jvi.01756-13
10.1128/jvi.01756-13 · External reference
A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoV
2020 · External reference
10.1126/science.abd0827
10.1126/science.abd0827 · External reference
Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing Strategy
2020 · External reference
Sequence variation of SARS-CoV-2 spike protein may facilitate stronger interaction with ACE2 promoting high infectivity
2020 · External reference
